Skip to main content
. 2021 Jul 16;65(8):e00552-21. doi: 10.1128/AAC.00552-21

TABLE 4.

Activity of CTB/VNRX-5236 and comparators against Enterobacterales expressing class A ESBLs, class A carbapenemases (KPC), class C cephalosporinases, and class D oxacillinasesa

Ambler class type Antimicrobial agent MIC range (μg/ml) MIC50 (μg/ml) MIC90 (μg/ml)
A-ESBLb CTB 0.12 to ≥64 8 ≥64
CTB/VNRX-5236 0.03–1 0.12 0.25
CTB/CLA 0.03 to ≥64 0.12 0.5
AMC 8 to ≥64 16 32
Sulopenem 0.03–1 0.12 0.5
Tebipenem ≤0.016–0.12 0.03 0.06
A-KPCc CTB 0.5 to ≥64 16 ≥64
CTB/VNRX-5236 0.06–1 0.12 1
CTB/CLA 0.25 to ≥64 8 ≥64
AMC 32 to ≥256 ≥64 ≥256
Sulopenem 4 to ≥64 32 ≥64
Tebipenem 8 to ≥64 ≥64 ≥64
Cd CTB 2 to ≥64 16 ≥64
CTB/VNRX-5236 0.03–2 0.12 1
CTB/CLA 0.06 to ≥64 2 ≥64
AMC 8 to ≥256 32 ≥256
Sulopenem 0.03–8 0.06 2
Tebipenem ≤0.016–2 0.06 0.5
De CTB 0.06 to ≥64 16 ≥64
CTB/VNRX-5236 0.03–2 0.12 1
CTB/CLA 0.06 to ≥64 4 32
AMC 128 to ≥256 ≥256 ≥256
Sulopenem 1 to ≥64 8 16
Tebipenem 0.5 to ≥64 4 16
a

CTB, ceftibuten; CTB/VNRX-5236, ceftibuten with VNRX-5236 fixed at 4 μg/ml (boldface); CTB/CLA, ceftibuten with clavulanic acid fixed at 4 μg/ml; AMC, amoxicillin with clavulanic acid tested at a 2:1 ratio.

b

Includes 12 strains of E. coli and 13 strains of K. pneumoniae.

c

Includes 1 strain of E. coli, 19 strains of K. pneumoniae, 3 strains of E. cloacae, and 2 strains of Klebsiella oxytoca.

d

Includes 7 strains of E. coli, 7 strains of K. pneumoniae, 3 strains of Klebsiella aerogenes, 6 strains of Serratia marcescens, 1 strain of Proteus mirabilis, and 1 strain of Citrobacter freundii.

e

Includes 12 strain of E. coli and 13 strains of K. pneumoniae.